SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001438533-24-000020
Filing Date
2024-05-06
Accepted
2024-05-06 16:46:22
Documents
98
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tvtx-20240331.htm   iXBRL 10-Q 1522808
2 EX-10.1 tvtx-03312024x10qxex101.htm EX-10.1 15873
3 EX-31.1 tvtx-03312024x10qxex311.htm EX-31.1 12709
4 EX-31.2 tvtx-03312024x10qxex312.htm EX-31.2 12407
5 EX-32.1 tvtx-03312024x10qxex321.htm EX-32.1 8767
6 EX-32.2 tvtx-03312024x10qxex322.htm EX-32.2 8847
12 GRAPHIC image_0.jpg GRAPHIC 48448
13 GRAPHIC tvtx-20240331_g1.jpg GRAPHIC 173675
  Complete submission text file 0001438533-24-000020.txt   9242996

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvtx-20240331.xsd EX-101.SCH 63214
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tvtx-20240331_cal.xml EX-101.CAL 104311
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tvtx-20240331_def.xml EX-101.DEF 386464
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvtx-20240331_lab.xml EX-101.LAB 754216
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvtx-20240331_pre.xml EX-101.PRE 582928
102 EXTRACTED XBRL INSTANCE DOCUMENT tvtx-20240331_htm.xml XML 1127899
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Filer) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36257 | Film No.: 24918271
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)